Galectin Therapeutics (GALT) Other Accumulated Expenses (2011 - 2015)

Galectin Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $6000.0 for Q3 2015.

• In Q3 2015, Other Accumulated Expenses rose 200.0% year-over-year to $6000.0; the TTM figure through Sep 2015 stood at $6000.0 (up 200.0% YoY), while the FY2014 annual figure was $7000.0, down 68.18% from the prior year.
• Other Accumulated Expenses was $6000.0 for Q3 2015 at Galectin Therapeutics, down from $7000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $98000.0 in Q1 2014 to a low of $2000.0 in Q2 2014.
• Historically, Other Accumulated Expenses has averaged $29800.0 across 5 years, with a median of $10000.0 in 2012.
• Biggest YoY gain for Other Accumulated Expenses was 790.91% in 2014; the steepest drop was 96.3% in 2014.
• A 5-year view of Other Accumulated Expenses shows it stood at $97000.0 in 2011, then slumped by 89.69% to $10000.0 in 2012, then surged by 120.0% to $22000.0 in 2013, then tumbled by 68.18% to $7000.0 in 2014, then slipped by 14.29% to $6000.0 in 2015.
• The last three Other Accumulated Expenses figures came in at $6000.0 (Q3 2015), $7000.0 (Q2 2015), and $72000.0 (Q1 2015), per Business Quant data.